Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Intas Pharmaceuticals Limited
FDA Inspection
•Intas Pharmaceuticals Limited•August 2, 2019

Intas Pharmaceuticals Limited – FDA Inspection, Aug 2, 2019

Record Details

This FDA Inspection record concerns Intas Pharmaceuticals Limited, with an inspection on August 2, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Intas Pharmaceuticals Limited
Inspection Date
August 2, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Rita K. Vick (Issuing Officer)
  • Thomas J. Arista
  • Yasamin Ameri (FDA Associated Person)
View Company Profile

ID · 0895eb6a-065a-49a6-ac84-da712eda4358

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1098380
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

14
  1. 21 CFR 211.46(c)Air recirculation of dust from production areas
  2. 21 CFR 211.42(c)(10)(iii)Air Supply
  3. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  4. 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
  5. 21 CFR 211.46(b)Equipment for Environmental Control
  6. 21 CFR 211.63Equipment Design, Size and Location
  7. 21 CFR 211.160(b)Scientifically sound laboratory controls
  8. 21 CFR 211.160(b)(4)Establishment of calibration procedures
  9. 21 CFR 211.113(b)Procedures for sterile drug products
  10. 21 CFR 211.113(b)Validation lacking for sterile drug products

Showing 10 of 14 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Intas Pharmaceuticals Limited

14
DateClassificationOfficeProject area
July 12, 2024NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
May 12, 2023Not classifiedOffice of Inspections and Investigations
December 14, 2018VAICenter for Drug Evaluation and ResearchGeneric Drug Evaluation
August 17, 2018Not classifiedOffice of Inspections and Investigations
June 8, 2018VAICenter for Veterinary MedicinePre-Approval Eval. of Animal Drugs and Food Additives
View all 14 other inspections on the company page
Other documents for Intas Pharmaceuticals Limited
  • FDA Inspection 1245599 - 2024-07-12
  • FDA Inspection 1206170 - 2023-05-12
  • FDA Inspection 1074349 - 2018-12-14
  • FDA Inspection 1067525 - 2018-08-17
  • FDA Inspection 1056170 - 2018-06-08

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Intas Pharmaceuticals Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.